The significance of different formulations of aerosolized colistin (multiple letters) [2]

Critical Care

Volumn 9, Issue 4, 2005, Pages 417-418

  Michalopoulus, Argyris ^a   Kasiakou, Sofia K ^b   Falagas, Matthew E ^a,b,c   Mubareka, S ^d   Rubinstein, E ^d  

^a HENRY DUNANT HOSPITAL   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; COLISTIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; AEROSOL; BACTERIAL PNEUMONIA; COUGHING; DRUG FORMULATION; DRUG INDICATION; DRUG TOLERABILITY; DRUG UTILIZATION; ENTEROCOCCUS; ERADICATION THERAPY; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PSEUDOMONAS; RISK ASSESSMENT; THORAX PAIN; THROAT DISEASE;

AEROSOLS; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; COLISTIN; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PNEUMONIA, BACTERIAL;

EID: 23744464079     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc3506     Document Type: Letter

References (0)